ERK activation drives cell proliferation, migration, and invasion through anti-apoptotic and proliferative signaling pathways [35,36], and ERK activation modulates cancer aggressiveness by the regulation of CD44 expression [12]. This evidence concerns the gene CD44 and cancer.